LeonaBio (LONA) Receivables - Other (2019 - 2024)

LeonaBio (LONA) has 6 years of Receivables - Other data on file, last reported at $4.1 million in Q4 2024.

• On a quarterly basis, Receivables - Other rose 157.94% year-over-year to $4.1 million in Q4 2024; TTM through Dec 2024 was $4.1 million, a 157.94% increase from a year earlier, with the FY2024 full-year figure at $4.1 million, up 157.94% from the prior year.
• Receivables - Other for Q4 2024 stood at $4.1 million, roughly flat from $4.1 million in the prior quarter.
• Over the last five years, Receivables - Other for LONA reached as high as $4.1 million in Q3 2024 and fell as low as $1.2 million in Q4 2022.
• Historically, Receivables - Other has averaged $2.3 million across 5 years, with a median of $2.1 million in 2021.
• Across the five-year window, Receivables - Other soared 18471.43% in 2020 and plunged 47.47% in 2022, its largest moves.
• Year by year, Receivables - Other stood at $1.3 million in 2020, then soared by 79.69% to $2.3 million in 2021, then tumbled by 47.47% to $1.2 million in 2022, then jumped by 30.4% to $1.6 million in 2023, then soared by 157.94% to $4.1 million in 2024.
• Per Business Quant data, the three most recent Receivables - Other figures were $4.1 million in Q4 2024, $4.1 million in Q3 2024, and $1.6 million in Q2 2024.